1-10 of 10
vascular endothelial growth factor inhibitors
Close
Sort by
Journal Articles

Phase II Study of VEGF Inhibitor, PTK787/ZK222584, in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma

Danielle M. Brander, MD, Anne W Beaven, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Cristina Gasparetto, MD, Thomas C. Shea, MD, Carlos deCastro, Joseph O. Moore, MD, David A. Rizzieri, MD
Journal: Blood
Blood (2012) 120 (21): 1626.
https://doi.org/10.1182/blood.V120.21.1626.1626
Published: 2012
Journal Articles

Angiogenic Blockade with Bevacizumab Does Not Increase Response to Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Myeloma

Andrew T Humbert, Rachel Cook, MS, MD, Thomas McFarland, Ronald Go, MD, Stephanie Markovina, MD, Shigeki Miyamoto, PhD, Eliot C. Williams, MD, PhD, Fotios Asimakopoulos, MBBChir, PhD, Jill Kolesar, PhD, Michael A. Thompson, MD, PhD, Kyungmann Kim, Natalie Callander, MD
Journal: Blood
Blood (2012) 120 (21): 5041.
https://doi.org/10.1182/blood.V120.21.5041.5041
Published: 2012
Journal Articles

Antiangiogenic Properties of a New VEGF Inhibitor Family : The Segetalins.

Roger Ourouda, Carole Amant, Sophie Nadascimento, Sabrina Kellouche, Agnes Boullier, Jean-Pierre Marolleau, Pascal Sonnet, Jacques Rochette
Journal: Blood
Blood (2009) 114 (22): 3038.
https://doi.org/10.1182/blood.V114.22.3038.3038
Published: 2009
Journal Articles

Increased Hemoglobin Associated with VEGF Inhibitors in Advanced Renal Cell Carcinoma

Lauren C. Harshman, M.D., Calvin J. Kuo, M.D., Ph.D., Bryan Y. Wong, M.D., Ph.D., Nicholas J. Vogelzang, M.D., Sandy Srinivas, M.D.
Journal: Blood
Blood (2008) 112 (11): 3453.
https://doi.org/10.1182/blood.V112.11.3453.3453
Published: 2008
Journal Articles

Treatment with JNJ-26483327 (Pan Her/Src/VEGFR-3 kinase inhibitor) Prolongs Survival of Mice Engrafted with Systemic Human Acute Myeloid Leukemia

Nathaniel C. Doro, Deepika Lal, Peter King, Eddy Freyne, Tim Perera, Eunice S. Wang, MD
Journal: Blood
Blood (2008) 112 (11): 4026.
https://doi.org/10.1182/blood.V112.11.4026.4026
Published: 2008
Journal Articles

Systemic VEGF Inhibition Induces Hepatic EPO Production and Erythrocytosis Via HIF-2a-Dependent and -Independent Mechanisms

Kevin Wei, BS, Aaron C. Logan, MD, PhD, Heather Wakelee, MD, M. Celeste Simon, Ph.D, Calvin J. Kuo, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 482.
https://doi.org/10.1182/blood.V112.11.482.482
Published: 2008
Journal Articles

Reversible Bony Changes after Treatment with Bevacizumab in a Child with Cutaneovisceral Angiomatosis with Thrombocytopenia Syndrome: A Case Report and Review of the Literature.

Angela R. Smith, MD, Hennessy Jane, PNP, Heisel Kurth Margaret, MD, Nelson C. Stephen, MD
Journal: Blood
Blood (2007) 110 (11): 1323.
https://doi.org/10.1182/blood.V110.11.1323.1323
Published: 2007
Journal Articles

Selenium Enhances the Anti-Angiogenic Effects of Bevacuzimab (Anti-VEGF Antibody) in Human Acute Myeloid Leukemia Xenograft Models.

Nathaniel C. Doro, BS, Deepika Lal, M.S., Youcef Rustum, Ph.D., Eunice S. Wang, M.D.
Journal: Blood
Blood (2007) 110 (11): 4216.
https://doi.org/10.1182/blood.V110.11.4216.4216
Published: 2007
Journal Articles

VEGF-TRAP Exhibits Potent In Vivo Anti-Tumor Activity in Acute Myeloid Leukemia Xenograft Models.

Deepika Lal, MS, Jennifer A. Park, Allison S. Drake, M.S., Brandon J. Hoelcle, Eunice S. Wang, MD
Journal: Blood
Blood (2006) 108 (11): 1987.
https://doi.org/10.1182/blood.V108.11.1987.1987
Published: 2006
Journal Articles

Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia

Brief Report
Srdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, Jorge Cortes, Francis J. Giles, Anna Rogers, Maher Albitar
Journal: Blood
Blood (2002) 99 (6): 2265–2267.
https://doi.org/10.1182/blood.V99.6.2265
Published: 2002